Search

everythinglearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

A male with aromatase deficiency improved bone health with estradiol treatment.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Low prolactin in young women may increase heart and metabolism risks.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.